Univercells
Latest round
- Series D
Last raised
- Oct 2022
Total raised
- $86M
Investors
- 16
About Univercells
Based in Belgium, and founded in 2013, Universals SA operates as a life sciences company that offers end-to-end biotech solutions to produce vaccines and biotherapeutics. The company was founded by its CEO, Hugues Bultot, and CTO, José Castillo. Universals provides products and services through its divisions: Univercells Technologies, a biomanufacturing firm that offers scale-X bioreactors; Exothera, a CDMO (contract development and manufacturing organization) that focuses on viral vectors targeting cell and gene therapy and vaccine development; Quantoom Biosciences, a biotech firm that offers Nfinity, an mRNA production platform; Unizima, a biomanufacturing company that provides biologics such as vaccines, monoclonal antibodies, and insulin; and RLM Consulting, a consulting firm that offers regulatory compliance for small and medium-sized biotech and pharmaceutical companies.
Who invested in Univercells
16 investors across 4 rounds
See all investors in Univercells
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Univercells
Who invested in Univercells?
Univercells has 16 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Univercells raised?
Univercells has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Univercells last raise money?
Univercells's most recent round on record is a Series D, in Oct 2022.
What does Univercells do?
Based in Belgium, and founded in 2013, Universals SA operates as a life sciences company that offers end-to-end biotech solutions to produce vaccines and biotherapeutics.
Where is Univercells headquartered?
Univercells is headquartered in Charleroi, Belgium.
Which VCs invest in companies like Univercells?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Univercells's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Univercells? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.